Total Payments
$21,752
2024 Payments
$342.73
Companies
18
Transactions
192
Medicare Patients
1,519
Medicare Billing
$255,762
Payment Breakdown by Category
Other$16,494 (75.8%)
Food & Beverage$3,251 (14.9%)
Travel$1,870 (8.6%)
Education$137.44 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,494 | 13 | 75.8% |
| Food and Beverage | $3,251 | 168 | 14.9% |
| Travel and Lodging | $1,870 | 8 | 8.6% |
| Education | $137.44 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $19,036 | 45 | $0 (2020) |
| ABBVIE INC. | $889.62 | 50 | $0 (2024) |
| Allergan, Inc. | $337.87 | 23 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $306.84 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $276.69 | 16 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $228.86 | 7 | $0 (2024) |
| ITI, Inc. | $93.41 | 5 | $0 (2023) |
| Eisai Inc. | $82.08 | 5 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $77.91 | 5 | $0 (2023) |
| Shire North American Group Inc | $77.27 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $342.73 | 16 | ABBVIE INC. ($170.28) |
| 2023 | $473.73 | 23 | Teva Pharmaceuticals USA, Inc. ($166.05) |
| 2022 | $487.50 | 28 | ABBVIE INC. ($316.09) |
| 2021 | $454.72 | 28 | AbbVie Inc. ($264.11) |
| 2020 | $424.13 | 27 | Allergan, Inc. ($216.05) |
| 2019 | $353.22 | 21 | Janssen Pharmaceuticals, Inc ($127.13) |
| 2018 | $8,854 | 31 | Otsuka America Pharmaceutical, Inc. ($8,630) |
| 2017 | $10,362 | 18 | Otsuka America Pharmaceutical, Inc. ($10,325) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Central Nervous System | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.03 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Neuroscience | ||||||
| 05/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: PSYCHIATRY | ||||||
| 05/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Neuroscience | ||||||
| 11/08/2023 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2023 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $99.00 | General |
| 09/20/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Central Nervous System | ||||||
| 09/13/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: INSOMNIA | ||||||
| 08/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 288 | 960 | $94,820 | $34,077 |
| 2022 | 10 | 528 | 2,007 | $301,136 | $90,875 |
| 2021 | 6 | 314 | 753 | $161,930 | $65,148 |
| 2020 | 5 | 389 | 933 | $197,110 | $65,663 |
Total Patients
1,519
Total Services
4,653
Medicare Billing
$255,762
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 310 | $74,400 | $26,500 | 35.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 19 | 19 | $7,600 | $2,680 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 30 | $4,500 | $1,941 | 43.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 115 | 580 | $5,800 | $1,898 | 32.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 19 | 21 | $2,520 | $1,058 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 399 | $95,760 | $35,077 | 36.6% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2022 | 13 | 280 | $112,000 | $25,009 | 22.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 58 | 58 | $23,200 | $8,280 | 35.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 30 | 187 | $23,936 | $6,568 | 27.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 30 | 151 | $19,328 | $5,713 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 70 | $10,500 | $4,358 | 41.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 148 | 796 | $7,960 | $2,645 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $4,320 | $1,660 | 38.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 21 | 25 | $3,030 | $1,216 | 40.1% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 29 | 29 | $1,102 | $346.90 | 31.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 133 | 459 | $109,449 | $43,488 | 39.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 46 | 46 | $18,400 | $7,143 | 38.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 97 | $14,318 | $6,258 | 43.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 45 | 85 | $10,343 | $4,542 | 43.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 25 | $9,000 | $3,566 | 39.6% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 21 | 41 | $420.00 | $151.29 | 36.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 121 | 467 | $112,080 | $37,686 | 33.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 94 | 213 | $31,950 | $10,399 | 32.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 79 | 79 | $31,600 | $8,804 | 27.9% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 82 | 154 | $18,480 | $7,645 | 41.4% |
About Dr. Tejaskumar Patel, MD
Dr. Tejaskumar Patel, MD is a Psychiatry healthcare provider based in Oro Valley, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902848096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tejaskumar Patel, MD has received a total of $21,752 in payments from pharmaceutical and medical device companies, with $342.73 received in 2024. These payments were reported across 192 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,494).
As a Medicare-enrolled provider, Patel has provided services to 1,519 Medicare beneficiaries, totaling 4,653 services with total Medicare billing of $255,762. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Psychiatry
- Location Oro Valley, AZ
- Active Since 06/12/2006
- Last Updated 12/19/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1902848096
Products in Payments
- ABILIFY MAINTENA (Drug) $14,070
- REXULTI (Drug) $5,015
- VRAYLAR (Drug) $1,227
- SPRAVATO (Drug) $211.86
- TRINTELLIX (Drug) $183.61
- CAPLYTA (Drug) $144.60
- INVEGA SUSTENNA (Drug) $94.98
- Trintellix (Drug) $93.08
- Dayvigo (Drug) $82.08
- QUVIVIQ (Drug) $77.91
- AUSTEDO (Drug) $71.02
- SUNOSI (Drug) $67.12
- ARISTADA (Drug) $65.80
- NEUROSTAR TMS THERAPY (Device) $60.71
- Austedo XR (Drug) $58.84
- VYVANSE (Drug) $40.48
- MYDAYIS (Drug) $36.79
- INGREZZA (Drug) $21.47
- Auvelity (Drug) $16.91
- LOREEV XR (Drug) $13.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.